Literature DB >> 7092278

Malignant angioendotheliomatosis proliferans treated with doxorubicin.

T M Keahey, D Guerry, R J Tuthill, E E Bondi.   

Abstract

An 84-year-old man was examined for progressive pain, edema, and infiltrating skin lesions on his lower extremities. A skin biopsy specimen confirmed the suspected diagnosis of angioendotheliomatosis proliferans. The clinical course and histologic changes suggested the malignant form of this disease. Treatment with intravenous doxorubicin hydrochloride caused a complete clinical remission.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092278

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  6 in total

1.  Malignant angioendotheliomatosis (Angiotropic lymphoma) of the gallbladder.

Authors:  L Laurino; M Melato
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Angiotropic large cell lymphoma presenting as interstitial lung disease.

Authors:  T B Tan; P J Spaander; M Blaisse; F M Gerritzen
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

Review 3.  Neoplastic angioendotheliosis: a case of subacute dementia with unusual cerebral CT appearances and a review of the literature.

Authors:  R S Knight; P Anslow; J M Theaker
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-08       Impact factor: 10.154

4.  Cellular characteristics of neoplastic angioendotheliosis. An immunohistological marker study of 6 cases.

Authors:  S Mori; S Itoyama; N Mohri; A Shibuya; T Hirose; R Takanashi; K Oshimi; H Mizoguchi; A E Epstein
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

5.  Malignant angioendotheliosis involving the nervous system: support for a lymphoid origin of the neoplastic cells.

Authors:  S E Daniel; P Rudge; F Scaravilli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

6.  Intravascular lymphomatosis: a clinicopathological study of three cases.

Authors:  U Liszka; M Drlicek; P Hitzenberger; E Machacek; H Mayer; G Stockhammer; W Grisold
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.